Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator-Reference-Cited by-同舟云学术

Brexpiprazole I: In Vitro and In Vivo Characterization of a Novel Serotonin-Dopamine Activity Modulator

Published:2014-06-19 Issue:3 Volume:350 Page:589-604
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Maeda Kenji,Sugino Haruhiko,Akazawa Hitomi,Amada Naoki,Shimada Jun,Futamura Takashi,Yamashita Hiroshi,Ito Nobuaki,McQuade Robert D.,Mørk Arne,Pehrson Alan L.,Hentzer Morten,Nielsen Vibeke,Bundgaard Christoffer,Arnt Jørn,Stensbøl Tine Bryan,Kikuchi Tetsuro

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference61 articles.

1. Strategies for pharmacotherapy of schizophrenia

2. Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI

3. Dopamine D-2 agonists with high and low efficacies: differentiation by behavioural techniques

4. Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence

5. Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

Cited by 286 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brexpiprazole for Agitation Associated With Dementia Due to Alzheimer's Disease;Journal of the American Medical Directors Association;2024-10

2. An overview of polypharmacology: A multifaceted approach to drug development;Tropical Journal of Pharmaceutical Research;2024-09-06

3. Update on Therapies in Older Adults;Medical Clinics of North America;2024-09

4. Current treatments in schizophrenia;Prescriber;2024-09

5. AMPA receptors modulate enhanced dopamine neuronal activity induced by the combined administration of venlafaxine and brexpiprazole;Neuropsychopharmacology;2024-08-15